As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Author(s)

• 

• Clyde W. Yancy, MD

  Magerstadt Professor of Medicine, Chief of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois

  Disclosures

  Disclosure: Clyde W. Yancy, MD, has disclosed no relevant financial relationships.
  
  Dr Yancy does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
  
  Dr Yancy does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

• 

• William T. Abraham, MD

  Professor of Internal Medicine; Director, Division of Cardiovascular Medicine; Deputy Director, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio

  Disclosures

  Disclosure: William T. Abraham, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Abbott Laboratories; BIOTRONIK; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; Respicardia, Inc.; St. Jude Medical; Sunshine Heart, Inc.; Zoll Medical Corporation
  
  Dr Abraham does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
  
  Dr Abraham does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

• 

• Anne B. Curtis, MD

  Charles and Mary Bauer Professor and Chair, Department of Medicine, University at Buffalo, Buffalo, New York; President and CEO, UBMD Internal Medicine, Amherst, New York

  Disclosures

  Disclosure: Anne B. Curtis, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Biosense Webster, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Medtronic, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Sanofi; St. Jude Medical; Pfizer Inc
  Served as a speaker or a member of a speakers bureau for: Medtronic, Inc.; St. Jude Medical
  
  Dr Curtis does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
  
  Dr Curtis does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor

• Ronald K. Miller, PhD

  Scientific Director, Medscape, LLC

  Disclosures

  Disclosure: Ronald K. Miller, PhD, has disclosed no relevant financial relationships.

Steering Committee

• Deepak L. Bhatt, MD, MPH

  Chief of Cardiology, VA Boston Healthcare System; Senior Physician, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School; Senior Investigator, TIMI Study Group, Boston, Massachusetts

  Disclosures

  Disclosure: Deepak L. Bhatt, MD, MPH, has disclosed the following relevant financial relationships:
  Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Eisai Inc.; Ethicon, Inc.; Medtronic, Inc.; sanofi-aventis; The Medicines Company; Medtronic, Inc.

• Roberta C. Bogaev, MD

  Assistant Professor of Medicine, Baylor College of Medicine, Houston, Texas; Private Practice Cardiologist, Schnitzler Cardiovascular Consultants, San Antonio, Texas

  Disclosures

  Disclosure: Roberta C. Bogaev, MD Roberta C. Bogaev, MD, has disclosed no relevant financial relationships.

• Ted E. Feldman, MD

  Professor of Medicine, Northwestern University School of Medicine, Evanston, Illinois

  Disclosures

  Disclosure: Ted E. Feldman, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Abbott Laboratories; Boston Scientific; Coherex Medical, Inc.; Edwards Lifesciences; Intervalve; Daiichi Sankyo, Inc.; Eli Lilly and Company; W.L. Gore & Associates, Inc.
  Served as a speaker or a member of a speakers bureau for: Boston Scientific Received grants for clinical research from: Abbott Laboratories; Boston Scientific; Edwards Lifesciences; St. Jude Medical; W.L. Gore & Associates, Inc.

• Jagmeet P. Singh, MD, PhD

  Associate Professor of Medicine, Cardiac Arrhythmia Service, Massachusetts General Hospital Heart Center, Harvard Medical School, Boston, Massachusetts

  Disclosures

  Disclosure: Jagmeet P. Singh, MD, PhD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: BIOTRONIK; Boston Scientific; Medtronic, Inc.; St. Jude Medical; Sorin Group; CardioInsight Technologies Inc.; Thoratec Corporation
  Served as a speaker or a member of a speakers bureau for: BIOTRONIK; Boston Scientific; St. Jude Medical; Sorin Group
  Received grants for clinical research from: BIOTRONIK; Boston Scientific; St. Jude Medical; Sorin Group; Medtronic, Inc.

CME Reviewer(s)

• Nafeez Zawahir, MD

  CME Clinical Director, Medscape, LLC

  Disclosures

  Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

• Laurie E. Scudder, DNP, NP

  Clinical Editor, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

  Disclosures

  Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.